Lbp Am Sa Has $29.04 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lbp Am Sa trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,625 shares of the medical equipment provider's stock after selling 5,179 shares during the quarter. Lbp Am Sa's holdings in Intuitive Surgical were worth $29,035,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the business. Castleark Management LLC raised its stake in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after buying an additional 2,990 shares during the period. Arlington Trust Co LLC boosted its holdings in shares of Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares in the last quarter. Aaron Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.2% in the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after acquiring an additional 78 shares during the last quarter. Ewing Morris & Co. Investment Partners Ltd. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $454,000. Finally, Whalerock Point Partners LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $209,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $527.30 on Wednesday. The stock has a market cap of $188.99 billion, a price-to-earnings ratio of 77.32, a P/E/G ratio of 5.67 and a beta of 1.64. The firm has a fifty day moving average of $537.77 and a 200-day moving average of $536.93. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the firm earned $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on ISRG shares. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Evercore ISI upped their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday. Finally, Robert W. Baird reduced their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $592.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.